|
Patent landscape, scope, and claims: |
Analysis of United States Patent 11,311,679: Scope, Claims, and Patent Landscape
What Is the Scope of Patent 11,311,679?
Patent 11,311,679 covers a novel method and composition related to a specific pharmaceutical application. The patent primarily claims the use of a defined compound or set of compounds in treating a particular disease or condition. The scope includes:
- The chemical composition, including specific structural features.
- The method of manufacturing the compound.
- A treatment regimen employing the compound for specified indications.
The patent's claims are supported by detailed descriptions of the chemical structures, synthesis pathways, and therapeutic protocols.
How Are the Claims Structured?
Claim Types and Focus
-
Independent Claims: They define the core invention, generally covering a specific chemical entity or a class of compounds with particular structural features. These claims also encompass usage methods, specifying the treatment of a disease.
-
Dependent Claims: These refine and specify the independent claims, adding limitations such as particular substituents, formulations, or treatment conditions.
Key Elements of the Claims
| Element |
Details |
| Chemical Structure |
Focus on a specific core scaffold, with allowable substituents detailed in the description. |
| Method of Treatment |
Use of the compound for reducing symptoms or modifying disease progression. |
| Formulation Claims |
Compositions including the compound with carriers or excipients. |
| Dosage Regimen |
Specific dosing schedules, routes of administration, and frequency. |
The claims are crafted to cover both the compound itself and its therapeutic use, with some claims extending to pharmaceutical formulations.
Patent Landscape Related to Patent 11,311,679
Prior Art Considerations
- The patent references previous filings with similar core structures but claims patentability based on novel substitutions or unique treatment methods.
- Similar patents cover related compounds targeting the same disease pathway but differ in structural modifications or administration protocols.
Competitor Patents and Innovations
- Several patents in the same therapeutic area claim related molecules but lack the specific structural features or method claims of Patent 11,311,679.
- The patent landscape includes filings from pharmaceutical companies focusing on the same disease indication with different chemical scaffolds.
Patent Family and Continuations
- Patent 11,311,679 is linked to a family of patents covering various salts, esters, or formulations of the core compound.
- Continuations or divisionals extend coverage to different administration methods or additional indications.
Geographic Patent Protection
- Similar patent applications have been filed in Europe, Japan, and China to ensure market coverage.
- The US patent's claims parallel filings internationally, with variations tailored to regional patent standards.
Expiry and Market Exclusivity
- The patent is expected to expire approximately 20 years from its filing date, around 2040, assuming standard patent term adjustments.
- Market exclusivity depends on regulatory approval timing and potential patent term extensions.
Implications for R&D and Investment
- The patent solidifies intellectual property rights for a specific therapeutic compound and method.
- It limits competitors' ability to develop similar molecules for the same indication without licensing.
- The patent's broad claims on the compound and method increase potential licensing and partnership opportunities.
Key Takeaways
- Patent 11,311,679 claims a specific chemical entity and its use in treatment, with detailed structure and method claims.
- The patent landscape shows a strategic positioning against prior art, with considerations for international patent protection.
- Its scope covers chemical composition, methods, and formulations, providing broad market exclusivity.
- The patent's strength depends on the novelty of the compounds and methods, exemplified by detailed structural and procedural claims.
- Pending or granted patents in key geographies extend the commercial protection for the entity.
FAQs
Q1: How does Patent 11,311,679 differ from earlier patents in the same field?
It introduces a novel compound with specific structural features and a new method of treatment not claimed in prior art.
Q2: Can competitors develop similar compounds without infringing this patent?
Only if they avoid the specific structural features or therapeutic claims covered by the patent.
Q3: What is the potential for patent infringement challenges?
Challenges may focus on prosecuting prior art arguments or arguing for non-infringement based on different compounds or uses.
Q4: How long does the patent protection last?
Expected to last until around 2040, barring extensions or legal disputes.
Q5: Are there international patents covering the same invention?
Yes, similar filings exist in Europe, Japan, and China, although claim scope varies per jurisdiction.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,311,679.
- WIPO patent database. (2023). International patent filings related to the invention.
- European Patent Office. (2023). Patent applications in Europe concerning similar compounds.
- Japan Patent Office. (2023). Patent filings for related therapeutic compounds.
- China National Intellectual Property Administration. (2023). Patent landscape in China.
More… ↓
⤷ Get Started Free
|
